Novel pyrrolopyrimidine derivatives: design, synthesis, molecular docking, molecular simulations and biological evaluations as antioxidant and anti-inflammatory agents. 2022

Amira I Sayed, and Yara E Mansour, and Mohamed A Ali, and Omnia Aly, and Zainab M Khoder, and Ahmed M Said, and Samar S Fatahala, and Rania H Abd El-Hameed
Pharmaceutical Organic Chemistry Department, Faculty of Pharmacy, Helwan University, Cairo, Egypt.

Current medical approaches to control the Covid-19 pandemic are either to directly target the SARS-CoV-2 via innovate a defined drug and a safe vaccine or indirectly target the medical complications of the virus. One of the indirect strategies for fighting this virus has been mainly dependent on using anti-inflammatory drugs to control cytokines storm responsible for severe health complications. We revealed the discovery of novel fused pyrrolopyrimidine derivatives as promising antioxidant and anti-inflammatory agents. The newly synthesised compounds were evaluated for their in vitro anti-inflammatory activity using RAW264.7 cells after stimulation with lipopolysaccharides (LPS). The results revealed that 3a, 4b, and 8e were the most potent analogues. Molecular docking and simulations of these compounds against COX-2, TLR-2 and TLR-4 respectively was performed. The former results were in line with the biological data and proved that 3a, 4b and 8e have potential antioxidant and anti-inflammatory effects.

UI MeSH Term Description Entries
D011743 Pyrimidines A family of 6-membered heterocyclic compounds occurring in nature in a wide variety of forms. They include several nucleic acid constituents (CYTOSINE; THYMINE; and URACIL) and form the basic structure of the barbiturates.
D011758 Pyrroles Azoles of one NITROGEN and two double bonds that have aromatic chemical properties. Pyrrole
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000086402 SARS-CoV-2 A species of BETACORONAVIRUS causing atypical respiratory disease (COVID-19) in humans. The organism was first identified in 2019 in Wuhan, China. The natural host is the Chinese intermediate horseshoe bat, RHINOLOPHUS affinis. 2019 Novel Coronavirus,COVID-19 Virus,COVID19 Virus,Coronavirus Disease 2019 Virus,SARS Coronavirus 2,SARS-CoV-2 Virus,Severe Acute Respiratory Syndrome Coronavirus 2,Wuhan Coronavirus,Wuhan Seafood Market Pneumonia Virus,2019-nCoV,2019 Novel Coronaviruses,COVID 19 Virus,COVID-19 Viruses,COVID19 Viruses,Coronavirus 2, SARS,Coronavirus, 2019 Novel,Coronavirus, Wuhan,Novel Coronavirus, 2019,SARS CoV 2 Virus,SARS-CoV-2 Viruses,Virus, COVID-19,Virus, COVID19,Virus, SARS-CoV-2,Viruses, COVID19
D000093485 COVID-19 Drug Treatment The use of DRUGS to treat COVID19 or its symptoms. COVID-19 Drug Therapy,COVID19 Drug Therapy,COVID19 Drug Treatment,Coronavirus Disease 2019 Drug Treatment,Coronavirus Disease-19 Drug Treatment,COVID 19 Drug Therapy,COVID 19 Drug Treatment,COVID-19 Drug Therapies,COVID19 Drug Therapies,COVID19 Drug Treatments,Coronavirus Disease 19 Drug Treatment,Drug Therapy, COVID-19,Drug Therapy, COVID19,Therapy, COVID-19 Drug,Therapy, COVID19 Drug,Treatment, COVID-19 Drug
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D058873 Pandemics Epidemics of infectious disease that have spread to many countries, often more than one continent, and usually affecting a large number of people. Pandemic
D062105 Molecular Docking Simulation A computer simulation technique that is used to model the interaction between two molecules. Typically the docking simulation measures the interactions of a small molecule or ligand with a part of a larger molecule such as a protein. Molecular Docking,Molecular Docking Simulations,Molecular Docking Analysis,Analysis, Molecular Docking,Docking Analysis, Molecular,Docking Simulation, Molecular,Docking, Molecular,Molecular Docking Analyses,Molecular Dockings,Simulation, Molecular Docking

Related Publications

Amira I Sayed, and Yara E Mansour, and Mohamed A Ali, and Omnia Aly, and Zainab M Khoder, and Ahmed M Said, and Samar S Fatahala, and Rania H Abd El-Hameed
July 2023, Chemistry & biodiversity,
Amira I Sayed, and Yara E Mansour, and Mohamed A Ali, and Omnia Aly, and Zainab M Khoder, and Ahmed M Said, and Samar S Fatahala, and Rania H Abd El-Hameed
February 2017, Bioorganic & medicinal chemistry letters,
Amira I Sayed, and Yara E Mansour, and Mohamed A Ali, and Omnia Aly, and Zainab M Khoder, and Ahmed M Said, and Samar S Fatahala, and Rania H Abd El-Hameed
October 2022, Bioorganic chemistry,
Amira I Sayed, and Yara E Mansour, and Mohamed A Ali, and Omnia Aly, and Zainab M Khoder, and Ahmed M Said, and Samar S Fatahala, and Rania H Abd El-Hameed
June 2022, International journal of molecular sciences,
Amira I Sayed, and Yara E Mansour, and Mohamed A Ali, and Omnia Aly, and Zainab M Khoder, and Ahmed M Said, and Samar S Fatahala, and Rania H Abd El-Hameed
September 2022, Chemistry & biodiversity,
Amira I Sayed, and Yara E Mansour, and Mohamed A Ali, and Omnia Aly, and Zainab M Khoder, and Ahmed M Said, and Samar S Fatahala, and Rania H Abd El-Hameed
October 2014, Chemical biology & drug design,
Amira I Sayed, and Yara E Mansour, and Mohamed A Ali, and Omnia Aly, and Zainab M Khoder, and Ahmed M Said, and Samar S Fatahala, and Rania H Abd El-Hameed
April 2005, Bioorganic & medicinal chemistry letters,
Amira I Sayed, and Yara E Mansour, and Mohamed A Ali, and Omnia Aly, and Zainab M Khoder, and Ahmed M Said, and Samar S Fatahala, and Rania H Abd El-Hameed
April 2017, European journal of pharmacology,
Amira I Sayed, and Yara E Mansour, and Mohamed A Ali, and Omnia Aly, and Zainab M Khoder, and Ahmed M Said, and Samar S Fatahala, and Rania H Abd El-Hameed
June 2023, BMC chemistry,
Amira I Sayed, and Yara E Mansour, and Mohamed A Ali, and Omnia Aly, and Zainab M Khoder, and Ahmed M Said, and Samar S Fatahala, and Rania H Abd El-Hameed
June 2012, Archives of pharmacal research,
Copied contents to your clipboard!